Saugus, MA, United States of America

Cristina LeChiara

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Cristina LeChiara in Pharmaceutical Sciences

Introduction

Cristina LeChiara, a notable inventor based in Saugus, Massachusetts, has made significant contributions to the field of pharmaceutical sciences. With a portfolio of eight patents, her innovations focus on developing effective drug formulations, particularly in the area of vancomycin therapies.

Latest Patents

Among her most recent inventions is a composition and method for vancomycin oral liquid. This invention relates to a stable vancomycin hydrochloride powder specifically designed for oral liquid formulations. The patent outlines methods for using these vancomycin oral liquid formulations to treat diseases such as pseudomembranous colitis and Staphylococcal enterocolitis, as well as the associated kits and related products. This work reflects her dedication to improving patient care through accessible and effective medication.

Career Highlights

Cristina has demonstrated leadership and innovation during her time with various pharmaceutical companies, notably Azurity Pharmaceuticals, Inc. and Cutispharma, Inc. Her expertise in the field has positioned her as a valuable asset, contributing to the development of important pharmaceutical solutions.

Collaborations

Throughout her career, Cristina has collaborated with esteemed colleagues such as Indu Muni and Peter Mione. These partnerships have enabled her to expand her research and enhance the impact of her inventions on the industry.

Conclusion

Cristina LeChiara continues to pave the way in pharmaceutical innovation with her groundbreaking work on vancomycin formulations. Her patents not only showcase her inventive spirit but also her commitment to addressing critical healthcare needs. As she progresses in her career, her contributions are likely to have lasting effects on both the pharmaceutical industry and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…